AzTrials
AzTrials

Caregiver StressPhase 2RechargeNCT07764185

Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease

A Phase 2 study testing Recharge Behavioral Therapy and Traditional Educational/Resources Program in people with Caregiver Stress, run by Photozig, Inc. at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This project will evaluate the effectiveness of the Recharge Behavioral Therapy (RBT) intervention to alleviate stress and depressive symptoms of caregivers of Individuals with Alzheimer's Disease and Related Dementia. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Caregiver Stress
What is being tested?
Recharge Behavioral Therapy and Traditional Educational/Resources Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteUnited States
Study dates
14 Aug 2026to 31 May 2027
Phase
Phase 2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Care for an individual with Alzheimer s Disease or other dementia.
  • Have a Smartphone or tablet with Internet access.
  • Minimum age of 18 years old.
  • Spend at least 8 hours/week caring for a person with dementia.

Who cannot join

  • Severe psychological or physical illness.
  • Inability to read and follow instructions.
  • Unwillingness to participate in all aspects of the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Bruno Kajiyama contact

855-955-CARE

caring@photozig.com

United States1 site, 1 recruiting
  • Photozig, Inc.

    Campbell, California, 95008

    Bruno Kajiyama, 855-955-2273, caring@photozig.com

    Recruiting

Other trials in United States

About this study

Official title: Recharge Behavioral Therapy for Caregivers of Individuals With Alzheimer's Disease

This project will evaluate the effectiveness of the Recharge Behavioral Therapy (RBT) intervention to alleviate stress and depressive symptoms of caregivers of Individuals with Alzheimer's Disease and Related Dementia.

Being tested
Recharge Behavioral Therapy, Traditional Educational/Resources Program
Medical subject headings
Caregiver Burden

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Recharge Behavioral TherapyBehavioural

    Participants will receive the Caring Recharge mobile app containing the Recharge Behavioral Therapy.

  • Traditional Educational/Resources ProgramBehavioural

    Participants will receive a traditional educational/resources program, containing a downloadable workbook and online resources.

Study groups in NCT07764185
Study groupRoleWhat they receive
Caring Recharge mobile appExperimentalParticipants will receive the Caring Recharge mobile app containing the Recharge Behavioral Therapy program.
Receives: Behavioral: Recharge Behavioral Therapy
Traditional educational programActive comparatorParticipants will receive a traditional educational/resources program, containing a downloadable workbook and online resources.
Receives: Behavioral: Traditional Educational/Resources Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Center for Epidemiological Studies Depression Scale

    The Center for Epidemiological Studies Depression scale (CES-D) is a 20-item measure that asks about the frequency of depressive symptoms (affective, psychological, and somatic) within the past week. The scale refers to the caregiver. Minimum score (best value)=0. Maximum score (worst value)=60. Higher values represent a worse outcome.

    Measured: 3 months

  2. Perceived Stress Scale

    The "Perceived Stress Scale" measures the overall level of stress. This instrument contains 10 items accessing overall appraisals of stress in the past month. The scale refers to the caregiver. Minimum score (best value)=0. Maximum score (worst value)=40. Higher values represent a worse outcome.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Aug 2026
  2. Study start14 Aug 2026
  3. Primary completion31 May 2027 (estimated)
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07764185
Sponsor's protocol ID
Pz-A110b
Other IDs
R44AG084419
Acronym
Recharge
Status last verified
Aug 2026
First submitted
9 Aug 2026
Last updated
21 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Recharge Behavioral Therapy and Traditional Educational/Resources Program in people with Caregiver Stress, run by Photozig, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 21 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Bruno Kajiyama (855-955-CARE, caring@photozig.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Center for Epidemiological Studies Depression Scale (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in